CNCure biotech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $4.59M

  • Investors
  • 9

CNCure biotech General Information

Description

Operator of a biotechnology company intended to provide expertise in drug development and cancer therapeutics. The company's offerings comprise an innovative microbial platform for cancer therapy, molecular imaging spies for making informed decisions, and a radio-theranostics platform for simultaneous diagnosis and treatment of diseases, providing healthcare professionals with science and technology that can diagnose diseases early and treat them to improve health conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • National Immunotherapy Innovation Center, Suite 303
  • 264 Seoyang-ro, Hwasun-eup, Hwasun-gun
  • Hwaseong, Jeollanam 58128
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • National Immunotherapy Innovation Center, Suite 303
  • 264 Seoyang-ro, Hwasun-eup, Hwasun-gun
  • Hwaseong, Jeollanam 58128
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CNCure biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 25-Jun-2026 $4.59M In Progress Clinical Trials - Phase 1
5. Accelerator/Incubator 14-Aug-2024 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 13-Jun-2022 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 01-Feb-2021 $6M $8M Completed Clinical Trials - Phase 1
1. Seed Round 01-Dec-2019 $2M $2M Completed Startup
To view CNCure biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CNCure biotech Patents

CNCure biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025100987-A1 Dna construct for expressing signaling substance for cancer treatment, and cancer treatment method using same Inactive 09-Nov-2023
AU-2022382621-A1 Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer Pending 05-Nov-2021
CA-3236831-A1 Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer Pending 05-Nov-2021
EP-4427755-A1 Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer Pending 05-Nov-2021
EP-4427755-A4 Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer Pending 05-Nov-2021 A61K35/74
To view CNCure biotech’s complete patent history, request access »

CNCure biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CNCure biotech Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
Hana Ventures Corporate Venture Capital Minority
ID Ventures (South Korea) Venture Capital Minority
Colopl Next Corporate Venture Capital Minority
DTN Investment (VC) Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

CNCure biotech FAQs

  • When was CNCure biotech founded?

    CNCure biotech was founded in 2019.

  • Where is CNCure biotech headquartered?

    CNCure biotech is headquartered in Hwaseong, South Korea.

  • What is the size of CNCure biotech?

    CNCure biotech has 15 total employees.

  • What industry is CNCure biotech in?

    CNCure biotech’s primary industry is Drug Discovery.

  • Is CNCure biotech a private or public company?

    CNCure biotech is a Private company.

  • What is CNCure biotech’s current revenue?

    The current revenue for CNCure biotech is .

  • How much funding has CNCure biotech raised over time?

    CNCure biotech has raised $12M.

  • Who are CNCure biotech’s investors?

    Johnson & Johnson Innovation - JLABS, Hana Ventures, ID Ventures (South Korea), Colopl Next, and DTN Investment (VC) are 5 of 9 investors who have invested in CNCure biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process